Viewing StudyNCT05838729



Ignite Creation Date: 2024-05-06 @ 6:55 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05838729
Status: RECRUITING
Last Update Posted: 2023-12-18
First Post: 2023-04-13

Brief Title: Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
Sponsor: Coordination Pharmaceuticals Inc
Organization: Coordination Pharmaceuticals Inc

Organization Data

Organization: Coordination Pharmaceuticals Inc
Class: INDUSTRY
Study ID: RiMO-HNC-IO1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Coordination Pharmaceuticals Inc
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
University of Illinois at Chicago OTHER